A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

Archives of General Psychiatry

Volumn 57, Issue 8, 2000, Pages 794-801

  McDougle, Christopher J ^a,e,f,g   Epperson, C Neill ^b   Pelton, Gregory H ^c   Wasylink, Suzanne ^b   Price, Lawrence H ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yale University School of Medicine ^*  (United States)

^d BROWN UNIVERSITY   (United States)

^e PFIZER INC   (United States)

^f JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^g Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; NORCLOMIPRAMINE; NORFLUOXETINE; PAROXETINE; PLACEBO; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROSIS; OBSESSION; RANDOMIZED CONTROLLED TRIAL; SEDATION; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME;

EID: 0033846191     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.8.794     Document Type: Article

References (31)

1. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis
2. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: Lack of efficacy
3. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive compulsive disorder
4. A controlled trial of clonazepam augmentation in OCD patients treated with clomipramine or fluoxetine
5. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder
6. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder: A double-blind, placebo-controlled study in patients with and without tics
7. Risperidone in the treatment of affective illness and obsessive-compulsive disorder
8. Risperidone addition in fluvoxamine-refractory obsessive compulsive disorder: Three cases
9. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder
10. Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD)
11. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders
12. Reliability and validity of the symptoms of major depressive illness
13. The Schedule for Schizotypal Personalities (SSP): A diagnostic interview for schizotypal features
14. Best estimate of lifetime psychiatric diagnosis: A methodologic study
15. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS), part I: Development, use, and reliability
16. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS), part II: Validity
17. The assessment of anxiety states by rating
18. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity
19. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
20. Risperidone: A novel anti-psychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity
21. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: Role of alpha-2-adrenoceptor antagonism
22. Potential of atypical antipsychotics in the treatment of nonpsychotic disorders
23. Lack of efficacy of clozapine monotherapy in refractory obsessive compulsive disorder
24. Emergence of obsessive-compulsive symptoms during treatment with clozapine
25. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia [letter]
26. Worsening of obsessive-compulsive symptoms following treatment with olanzapine
27. Obsessive-compulsive symptoms with neuroleptics
28. Tardive dyskinesia induced by risperidone?